Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome
Clinical trial NCT05330845 · TERMINATED
Trial details
- NCT number
- NCT05330845
- Sponsor
- Centre Hospitalier Henri Duffaut - Avignon
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-05
- Primary completion
- 2022-03-24
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.